FdaApplication
BLA 761275
Identifiers
- fda_app_no: BLA761275
Properties
| Property | Value |
|---|---|
| applicant_name | Fresenius Kabi USA, LLC |
| application_type | BLA |
| approval_date | 2024-03-05 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TYENNE | TOCILIZUMAB-AAZG | 400MG/20ML (20MG/ML) | Injection |
| TYENNE | TOCILIZUMAB-AAZG | 200MG/10ML (20MG/ML) | Injection |
| TYENNE | TOCILIZUMAB-AAZG | 400MG/20ML | INJECTABLE;INTRAVENOUS |
| TYENNE | — | 80MG/4ML (20MG/ML) | Injection |
4 products